Cargando…

Patient‐reported ‘ever had’ and ‘current’ long‐term physical symptoms after prostate cancer treatments

OBJECTIVE: To investigate the prevalence of physical symptoms that were ‘ever’ and ‘currently’ experienced by survivors of prostate cancer at a population level, to assess burden and thus inform policy to support survivors. PATIENTS AND METHODS: The study included 3 348 men surviving prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gavin, Anna T., Drummond, Frances J., Donnelly, Conan, O'Leary, Eamonn, Sharp, Linda, Kinnear, Heather R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Urological Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008189/ https://www.ncbi.nlm.nih.gov/pubmed/25597493 http://dx.doi.org/10.1111/bju.13036

Ejemplares similares

Mode of prostate cancer detection is associated with the psychological wellbeing of survivors: results from the PiCTure study
por: Drummond, Frances J., et al.
Publicado: (2015)

Effect of investigation intensity and treatment differences on prostate cancer survivor's physical symptoms, psychological well-being and health-related quality of life: a two country cross-sectional study
por: Gavin, Anna T, et al.
Publicado: (2016)

Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis
por: Protopapa, Eva, et al.
Publicado: (2020)

Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate Cancer Treatment, your experience (PiCTure) study
por: Drummond, F J, et al.
Publicado: (2015)

Resveratrol in prostate diseases
por: Salagierski, Maciej
Publicado: (2013)

Inflammatory changes and the prostate
por: Soloway, Mark S.
Publicado: (2013)

Current Trends in Incidence and Management of T1a and T1b Prostate Cancer
por: Khan, Firaas A, et al.
Publicado: (2023)

Obesity and prostate cancer research
por: Van den Broeck, Thomas, et al.
Publicado: (2013)

Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement
por: Merriel, Samuel W.D., et al.
Publicado: (2019)

Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies
por: Steuber, Thomas, et al.
Publicado: (2018)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Education concerning carcinoma of prostate and its early detection
por: Dutkiewcz, Sławomir, et al.
Publicado: (2011)

Prostate cancer recurrence – new prognostic factors are needed
por: Wajsman, Zew
Publicado: (2013)

Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019)

β-catenin as a prognostic factor for prostate cancer (PCa)
por: Nowicki, Andrzej, et al.
Publicado: (2012)

Outcome of surgery in locally advanced pT3a prostate cancer
por: Milonas, Daimantas, et al.
Publicado: (2011)

Complication rates after prostate biopsy according to the number of sampled cores
por: Madej, Adam, et al.
Publicado: (2012)

Predicting biochemical recurrence and prostate cancer‐specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening‐ and clinically detected prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2019)

Pain, fatigue and depression symptom cluster in survivors of prostate cancer
por: Baden, Manisha, et al.
Publicado: (2020)

United in Fight against prOstate cancer (UFO) registry: first results from a large, multi‐centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia
por: Uemura, Hirotsugu, et al.
Publicado: (2020)

Active surveillance for low-risk prostate cancer: well established, yet avoided?
por: Sosnowski, Roman, et al.
Publicado: (2022)

Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System
por: da Silva, Anna Carolina Borges, et al.
Publicado: (2023)

A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
por: Connell, Shea P., et al.
Publicado: (2019)

Distribution of prostate cancer recurrences on gallium‐68 prostate‐specific membrane antigen ((68)Ga‐PSMA) positron‐emission/computed tomography after radical prostatectomy with pathological node‐positive extended lymph node dissection
por: Huits, Thijs H., et al.
Publicado: (2020)

COmparing Urolift and Standard Transurethral resection of prostate Ahead of Radiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study
por: Wong, Kathie, et al.
Publicado: (2023)

Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations
por: Bancroft, Elizabeth K., et al.
Publicado: (2018)

The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression
por: Wollersheim, Barbara M., et al.
Publicado: (2019)

Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer
por: Mori, Keiichiro, et al.
Publicado: (2021)

Optimising the number of cores for magnetic resonance imaging‐guided targeted and systematic transperineal prostate biopsy
por: Hansen, Nienke L., et al.
Publicado: (2019)

Current Status of Monoclonal Antibodies-Based Therapies in Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis of Clinical Trials
por: Tarrar, Talha Azam, et al.
Publicado: (2022)

Moxibustion as an adjuvant for benign prostatic hyperplasia with lower urinary tract symptoms: a protocol for a parallel-group, randomised, controlled pilot trial
por: Lee, Hye-Yoon, et al.
Publicado: (2015)

Is a functional urinary bladder attainable through current regenerative medicine strategies?
por: Sharma, Arun K.
Publicado: (2013)

An observational, multicentre study of cabazitaxel in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel (CAPRISTANA)
por: Carles, Joan, et al.
Publicado: (2018)

The impact of adjuvant therapy in patients with biochemical recurrence on prostate cancer progression and mortality five years after radical prostatectomy
por: Fryczkowski, Mieczysław, et al.
Publicado: (2011)

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery
por: Badani, Ketan K, et al.
Publicado: (2015)

Current status and progression of lower urinary tract symptoms in Chinese male patients: the protocol and rationale for a nationwide, hospital-based, prospective, multicentre study
por: Song, Qi-Xiang, et al.
Publicado: (2019)

Reliability and validity of assessment methods available in primary care for bladder outlet obstruction and benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review
por: Vredeveld, Tom, et al.
Publicado: (2022)

Focal Cryoablation of the Prostate: Primary Treatment in 163 Patients With Localized Prostate Cancer
por: Khan, Anwar, et al.
Publicado: (2023)

Clinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection
por: Rojas-Manrique, Juan P, et al.
Publicado: (2019)

Disseminated Intravascular Coagulation With Excessive Fibrinolysis Following Diagnostic Prostatic Biopsy for Prostate Cancer
por: Ghallab, Muhammad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v9rdnaeoau66kl66r462nrpi6r